文献速递泌尿生殖妇产影像PETCTMR

PET/CT与PET/MR在卵巢癌管理中的诊断效能——文献综述

Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.
PubMed 文献 · Abdom Radiol (NY) · 2020-11-11

本文综述了PET/CT与PET/MRI在卵巢癌管理中的作用,指出卵巢癌常晚期发现且易复发,准确分期与再分期对改善治疗结局和判断预后至关重要;混合成像PET/CT与PET/MRI正成为有潜力的无创成像工具。

要点

  • 卵巢癌常晚期发现且虽经最佳治疗仍频繁复发。
  • 准确分期与再分期对改善治疗结局和判断预后至关重要。
  • PET/CT与PET/MRI正成为改善卵巢癌管理的有潜力的无创成像工具。

核心结论

  • PET/CT与PET/MRI正成为改善卵巢癌管理的有潜力的无创成像工具。

研究设计与样本

  • 文献综述,讨论PET/CT与PET/MRI在卵巢癌中的作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ovarian cancer is a challenging disease. It often presents at an advanced stage with frequent recurrence despite optimal management. Accurate staging and restaging are critical for improving treatment outcomes and determining the prognosis. Imaging is an indispensable component of ovarian cancer management. Hybrid imaging modalities, including positron emission tomography/computed tomography (PET/CT) and PET/magnetic resonance imaging (MRI), are emerging as potential non-invasive imaging tools for improved management of ovarian cancer. This review article discusses the role of PET/CT and PET/MRI in ovarian cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Virarkar M, Ganeshan D, Gulati AT, et al. Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review. Abdom Radiol (NY). 2020. PMID: 33175199. doi:10.1007/s00261-020-02847-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。